Roche acquires genomic analysis startup Bina

Pharmaceutical and diagnostics company Roche has bought Bina Technologies, a startup that built hardware and software for genomic analysis.

The startup’s technologies made a big difference for researchers who sought to pore over genomic data. Genetic analysis can take a few hours for $ 200, instead of thousands of dollars and weeks or months, VentureBeat reported last year.

“This merger provides us with the resources, knowledge, and expertise to substantially grow our business and product capabilities,” Bina chief executive Narges Bani Asadi wrote in a blog post on the news. The Bina team will be able to sell its Genomic Management Solutions to drug companies and academic institutions around the world, she wrote.

Bina started in 2011 and was based in Redwood City, Calif. Investors include Sierra Ventures, Jerry Yang, and Mohsen Moazami. Pilot customers included Stanford Genetics Department and the VA Palo Alto hospital.

More information:

Bina Technologies is pioneering a new approach to solving the big data challenges in Genomics and Personalized Medicine. Bina’s combination of high-performance computing expertise combined with our proprietary statistical algorithms an… read more »

Powered by VBProfiles

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
Want something else to read? How about ‘Grievous Censorship’ By The Guardian: Israel, Gaza And The Termination Of Nafeez Ahmed’s Blog

VentureBeat » Big Data News | VentureBeat